Medtronic PLC MDT
88.64
0.13
0.15%
as of 25 Sep
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Medtronic PLC (MDT) Free cash flow
Medtronic PLC's free cash flow for fiscal 2026 was $5.4B, unchanged from fiscal 2025. Over the twelve months to 31 July 2026 it was $6.1B. Over the past ten years it has ranged from $3.6B (fiscal 2018) to $6.0B (fiscal 2020); the current reading is higher than 67% of that period. Medtronic PLC ranks 2nd of 149 Medical Devices companies by free cash flow.
Free cash flow, annual
Annual
| Period | Free cash flow | Change |
|---|---|---|
| FY2026 | $5.4B | 4.65% |
| FY2025 | $5.2B | (0.29%) |
| FY2024 | $5.2B | 13.54% |
| FY2023 | $4.6B | (23.39%) |
| FY2022 | $6.0B | 22.37% |
| FY2021 | $4.9B | (18.87%) |
| FY2020 | $6.0B | 2.52% |
| FY2019 | $5.9B | 62.42% |
| FY2018 | $3.6B | (35.73%) |
| FY2017 | $5.6B | 34.85% |
Quarterly
| Period | Free cash flow | Change |
|---|---|---|
| Jul 2026 | $1.3B | (38.13%) |
| Apr 2026 | $2.1B | (9.35%) |
| Jan 2026 | $2.3B | 403.28% |
| Oct 2025 | $457.0M | (21.75%) |
| 43 more quarters | Free account |
Against its own ten years
Low $3.6B
High $6.0B
Ten-year median
$5.2B
Current reading's percentile
67
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| ABT Abbott Laboratories compare | $7.8B |
| MDT Medtronic PLC | $6.1B |
| SYK Stryker Corporation compare | $4.7B |
| BSX Boston Scientific Corporation compare | $3.6B |
| PHG Koninklijke Philips N.V. compare | $1.8B |
| GEHC GE HealthCare Technologies Inc. compare | $1.6B |
| EW Edwards Lifesciences Corporation compare | $1.4B |
| DXCM DexCom, Inc. compare | $1.4B |
| STE STERIS plc compare | $936.0M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on MDT
- Revenue
- Net income
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement